CoTherix
CoTherix, Inc. was a biopharmaceutical company located in South San Francisco, California. CoTherix focused on licensing, developing, and commercializing therapeutic products for the treatment of cardiopulmonary and other chronic diseases. The company, formerly known as Exhale Therapeutics, Inc., was founded in February 2000 by Gerard Turino, MD, a past president of the American Thoracic Society, and Jerome Cantor, MD, a pulmonary pathologist. CoTherix inlicensed Fasudil from Asahi Kasei and its commercialization rights in the U.S. and Europe.
primaryTopic
CoTherix
CoTherix, Inc. was a biopharmaceutical company located in South San Francisco, California. CoTherix focused on licensing, developing, and commercializing therapeutic products for the treatment of cardiopulmonary and other chronic diseases. The company, formerly known as Exhale Therapeutics, Inc., was founded in February 2000 by Gerard Turino, MD, a past president of the American Thoracic Society, and Jerome Cantor, MD, a pulmonary pathologist. CoTherix inlicensed Fasudil from Asahi Kasei and its commercialization rights in the U.S. and Europe.
has abstract
CoTherix, Inc. was a biopharma ...... each share of CoTherix stock.
@en
extinction date
2007-01-09
extinction year
fate
acquired byActelion
@en
founding year
industry
key person
location
number of employees
product
revenue ($)
type
Link from a Wikipage to an external page
Wikipage page ID
Wikipage revision ID
659,152,733
Product page
Slogan
Developing and Commercializing New Therapies for Life-Threatening Diseases.
subject
comment
CoTherix, Inc. was a biopharma ...... rights in the U.S. and Europe.
@en
label
CoTherix
@en
wasDerivedFrom
homepage
isPrimaryTopicOf
name
CoTherix, Inc.
@en